Results
Extera's Partners have sold companies with a total value of over $1 billion, closed over $2 billion in alliances, including two of the largest strategic licensing agreements of the last decade, started eight companies and have raised over $250 million in venture investment.



Option to Buy Agreement

$ Undisclosed
Autoimmune Diseases


Collaboration Agreement 

$500,000,000
Ocology


Collaboration Agreement with 

$350,000,000
Inflammation


Acquisition by 

$300,000,000
Surgical Tools


Licensing  Option & Follow-on M&A

$130,000,000
Pain


Licensing Agreement

$95,000,000
Oncology


Acquisition by

$93,000,000
Surgical Tools


Private Placement by Multiple Venture Investors

$87,000,000
Ophthalmology


Acquisition by

$83,000,000
Imaging


Licensing Agreement

$75,000,000
Ophthalmology


Licensing Agreement

$30,000,000
Pain


Private Placement by Multiple Venture Investors

$28,000,000
Orthopedics


Private Placement by Multiple Venture Investors

$21,000,000
Nano Fibers


Private Placement by Multiple Venture Investors

$16,000,000
Audiology


Licensing Agreement

$10,000,000
Aptamers


Private Placement by Family Offices

$8,000,000
Pian


Private Placement by Family Offices

$5,000,000
Inflammation


Series B Private Placement

$8,150,000
Rare Genetic Diseases


Acquisition by

$59,000,000
Ophthalmology


Transactions with Limited Public Disclosures



Acquisition by

$ Undisclosed
Spectroscopy


Licensing Agreement

$ Undisclosed
Drug Delivery


Licensing Agreement

$ Undisclosed
Infectious Diseases


Licensing Agreement

Undisclosed Global Pharma Partner

$ Undisclosed
Diabetes


Private Placement by Multiple Venture Investors

$ Undisclosed
Neurosurgery


Private Placement by Multiple Venture Investors

$ Undisclosed
Audiology


Private Placement by Multiple Venture Investors

$ Undisclosed
Clinical Imaging


Distribution Agreement

$ Undisclosed
Wound Care


Distribution Agreement

With Multiple Partners


$ Undisclosed
Orthopedics


Distribution Agreement

$ Undisclosed
Ophthalmology


Distribution Agreement

$ Undisclosed
Gastrointestinal